Treatment of Antimicrobial Resistant STIs: Mycoplasma Genitalium, Gonorrhoea and Others

Details

Date & Time

Thursday 8th May @ 6:30 pm - 8:30 pm

Venue

Online, ZOOM

Organiser

VHHITAL

CPD details

Educational Activities 2.0 hours
Measuring Outcomes 00 hours
Reviewing Performance 00 hours
  • This event has passed.

Date

Thursday 8th May @ 6:30 pm – 8:30 pm

Venue

Online

ZOOM

Organiser

VHHITAL

Educational
Activities

2

Both Mycoplasma Genitalium (MG) and Gonorrhoea are relatively common in Australia. Both STIs have developed anti-microbial resistance in recent years, rendering them increasingly difficult to treat.

Hosted by the Victorian HIV and Hepatitis Integrated Training and Learning program, this session will cover effective methods of testing and treatment in the presence of antimicrobial resistance. 

CPD hours General practice STI

Related events

Austin Health: Wound Care – Together We Heal

By Austin Health

Austin Health HIP Wound Care Education Day on 05/06/2025
General practice

MPA/MIA Melanoma Community Webinar Series

By Melanoma Institute Australia

Join us for an engaging series of live webinars designed for people living with melanoma and their carers.
Allied health

My Health Record in Aged Care

By VTPHNA

Residential Aged Care Home (RACH) clinicians and staff are invited to attend a free 45-minute webinar on My Health Record in aged care. Presented by the Victorian and Tasmanian PHN Alliance (VTPHNA), on behalf of the Australian Digital Health Agency, this webinar will focus on supporting RACH’s who haven’t registered for the MHR system, or are about to start the registration process.  
Aged care General practice

Was this content helpful to you?

Yes
No
Thanks for your feedback!

Subscribe to EMPHN news

Keep up to date with the latest news and publications, funding opportunities, careers and upcoming events at EMPHN.

Subscribe

Follow us on LinkedIn

Follow us on LinkedIn to stay informed with latest news, events and initiatives from our organisation and healthcare network.

Follow us